Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Hanly, John GSu, Li
Urowitz, Murray B
Romero-Diaz, Juanita
Gordon, Caroline
Bae, Sang-Cheol
Bernatsky, Sasha
Clarke, Ann E
Wallace, Daniel J
Merrill, Joan T
Isenberg, David A
Rahman, Anisur
Ginzler, Ellen M
Petri, Michelle
Bruce, Ian N
Dooley, M A
Fortin, Paul
Gladman, Dafna D
Sanchez-Guerrero, Jorge
Steinsson, Kristjan
Ramsey-Goldman, Rosalind
Khamashta, Munther A
Aranow, Cynthia
Alarcón, Graciela S
Fessler, Barri J
Manzi, Susan
Nived, Ola
Sturfelt, Gunnar K
Zoma, Asad A
van Vollenhoven, Ronald F
Ramos-Casals, Manuel
Ruiz-Irastorza, Guillermo
Lim, S Sam
Kalunian, Kenneth C
Inanc, Murat
Kamen, Diane L
Peschken, Christine A
Jacobsen, Soren
Askanase, Anca
Theriault, Chris
Thompson, Kara
Farewell, Vernon
Journal title
Arthritis & rheumatology (Hoboken, N.J.)Publication Volume
67Publication Issue
7Publication Begin page
1837Publication End page
47
Metadata
Show full item recordAbstract
To examine the frequency, characteristics, and outcome of mood disorders, as well as clinical and autoantibody associations, in a multiethnic/racial, prospective inception cohort of patients with systemic lupus erythematosus (SLE).Patients were assessed annually for mood disorders (4 types, according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) and 18 other neuropsychiatric events. Global disease activity scores (SLE Disease Activity Index 2000 [SLEDAI-2K]), damage scores (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index [SDI]), and Short Form 36 subscales, mental and physical component summary scores were collected. Time to event, linear and ordinal regressions, and multi-state models were used as appropriate.
Among the 1,827 patients with SLE, 88.9% were female, and 48.9% were Caucasian. The mean ± SD age of the patients was 35.1 ± 13.3 years, disease duration was 5.6 ± 4.8 months, and the length of followup was 4.7 ± 3.5 years. During the course of the study, 863 (47.2%) of the 1,827 patients had 1,627 neuropsychiatric events. Mood disorders occurred in 232 (12.7%) of 1,827 patients, and 98 (38.3%) of 256 mood disorder events were attributed to SLE. The estimated cumulative incidence of any mood disorder after 10 years was 17.7% (95% confidence interval 15.1, 20.2%). A greater risk of mood disorder was associated with concurrent neuropsychiatric events (P ≤ 0.01), and a lower risk was associated with Asian race/ethnicity (P = 0.01) and treatment with immunosuppressive drugs (P = 0.003). Mood disorders were associated with lower mental health and mental component summary scores but not with the SLEDAI-2K, SDI, or lupus autoantibodies. Among the 232 patients with depression, 168 (72.4%) were treated with antidepressants. One hundred twenty-six (49.2%) of 256 mood disorders resolved in 117 (50.4%) of 232 patients.
Mood disorders, the second most frequent neuropsychiatric event in patients with SLE, have a negative impact on health-related quality of life and improve over time. The lack of association with global SLE disease activity, cumulative organ damage, and lupus autoantibodies emphasizes the multifactorial etiology of mood disorders and a role for non-lupus-specific therapies.
Citation
Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2015 Jul;67(7):1837-47. doi: 10.1002/art.39111. PMID: 25778456; PMCID: PMC4485527.DOI
10.1002/art.39111ae974a485f413a2113503eed53cd6c53
10.1002/art.39111
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2015, American College of Rheumatology.